Literature DB >> 18347763

[Effectiveness of radiofrequency ablation of lung tumours ].

K-H Schultheis1, R Schroeder-Finckh, A Schultheis, R Kappes, F Sommerer, A Tannapfel.   

Abstract

BACKGROUND: There has been great success in the treatment of primary and secondary tumours of the liver using radiofrequency ablation (RFA) therapy, resulting in this method being used for other solid tumours such as in the lung. However, concerning lung cancer only few data are available about the histomorphological effects of this method. The aim of this study was to analyse the effects of RFA therapy in tumours of the lung. PATIENTS AND METHODS: Eleven patients with non-small-cell lung cancer and one with a lung metastasis (primary tumour identified as urothelial carcinoma) underwent RFA therapy followed by resection of the affected lobe. One patient with a metastasis of the liver was included for comparison of treatment effects. Histomorphological analysis of the collected material was used to measure the amount of necrosis.
RESULTS: None of the treated tumours of the lung showed complete necrosis after applying RFA therapy. In contrast, this method with the control metastasis of the liver resulted in complete thermal destruction.
CONCLUSION: Our results indicate that RFA therapy is not adequate for successful induction of necrosis in tumours of the lung. Therefore the use of this method has to be considered extremely carefully as a palliative treatment option in tumours of the lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347763     DOI: 10.1007/s00104-008-1493-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  30 in total

Review 1.  [Percutaneous radiofrequency ablation -- clinical indications and results].

Authors:  J Tacke
Journal:  Rofo       Date:  2003-02

2.  Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation.

Authors:  Osamu Hataji; Koichiro Yamakado; Atsuhiro Nakatsuka; Shuichi Murashima; Hajime Fujimoto; Yoichi Nishii; Hiroki Nakahara; Hiroyasu Kobayashi; Esteban C Gabazza; Osamu Taguchi
Journal:  Intern Med       Date:  2005-08       Impact factor: 1.271

3.  Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.

Authors:  Brent D Weinberg; Ravi B Patel; Agata A Exner; Gerald M Saidel; Jinming Gao
Journal:  J Control Release       Date:  2007-08-25       Impact factor: 9.776

4.  Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.

Authors:  Christophe L Nguyen; Walter J Scott; Nancy A Young; Tina Rader; Lydia R Giles; Melvyn Goldberg
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

5.  Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model.

Authors:  S B Chinn; F T Lee; G D Kennedy; C Chinn; C D Johnson; T C Winter; T F Warner; D M Mahvi
Journal:  AJR Am J Roentgenol       Date:  2001-03       Impact factor: 3.959

6.  Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study.

Authors:  Marcello Carlo Ambrogi; Gabriella Fontanini; Roberto Cioni; Pinuccia Faviana; Olivia Fanucchi; Alfredo Mussi
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

7.  [Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review].

Authors:  T J Vogl; R Straub; T Lehnert; K Eichler; T Lüder-Lühr; J Peters; S Zangos; O Söllner; M Mack
Journal:  Rofo       Date:  2004-11

8.  Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.

Authors:  Damian E Dupuy; Thomas DiPetrillo; Sachin Gandhi; Neal Ready; Thomas Ng; Walter Donat; William W Mayo-Smith
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

9.  Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.

Authors:  Masao Akeboshi; Koichiro Yamakado; Atsuhiro Nakatsuka; Osamu Hataji; Osamu Taguchi; Motoshi Takao; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

10.  Bronchial arteries in various stages of bronchogenic carcinoma.

Authors:  K M Müller; M Meyer-Schwickerath
Journal:  Pathol Res Pract       Date:  1978-09       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.